Syngene International

Incorporated in 1993, Syngene is headquartered in Bangalore, Karnataka, India. The company is a subsidiary of Biocon Ltd. Syngene has a talent pool of 5,656 scientists and trailing twelve month revenue of $423M. The company's services cover chemistry, biology, safety assessment and toxicology, computational and data sciences, recombinant DNA engineering, cell line development, next-generation sequencing, hybridoma technology, and protein sciences. It has 400+ active customers with engagements with 13 out of the top 15 global pharma companies.

Syngene recently expanded its global footprint with the acquisition of a biologics manufacturing facility in Baltimore, Maryland, United States. Syngene is recognized by TIME Magazine and Statista as one of the "World's Most Sustainable Companies, 2025." The company operates over 3 million square feet of specialized discovery, development, and manufacturing facilities across India and the U.S., working with approximately 400 global customers across industry segments, including biotech companies pursuing leading-edge science and multinationals such as BMS, GSK, Zoetis, and Merck KGaA.

Recent Leadership News

Siddharth Mittal assumed the role of Managing Director and Chief Executive Officer effective July 1, 2026, succeeding Peter Bains who completed his tenure on June 30, 2026. Mittal joins from Biocon Limited, where he served as Managing Director and CEO, bringing thirteen years at Biocon including service as Chief Financial Officer. Effective May 1, 2026, Maninder Kapoor Puri joined as Chief Human Resources Officer, and Abhijit Zutshi as Chief Commercial Officer.

This is an automatically generated Light company page created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.